MAY 23, 2020 2:27 PM PDT

The FDA Yanks Some COVID-19 Antibody Tests From the Market

WRITTEN BY: Carmen Leitch

The SARS-CoV-2 pandemic virus has rapidly spread around the world, causing millions of infections and thousands of deaths. The massive demand for diagnostic testing led the Food and Drug Administration (FDA) to open a short window to allow many testing products to go to market without being independently verified, as long as companies did their own testing and notified consumers that the tests had not been validated by another agency.

On May 4, the FDA told the makers of 29 of these tests that it was time for them to be reviewed (leaving 12 antibody tests still available). Now, the FDA is taking some of these tests off the market - find a list here, and more may be removed in the future.

“Our action today is an important step the agency has taken to ensure that Americans have access to trustworthy tests,” said FDA Commissioner Stephen M. Hahn, M.D. “We have seen a high level of collaboration and engagement from developers who want to get this right, and we continue to be available to work extensively with industry to help them with developing accurate tests for the public.”

Stopping the spread of a highly infectious pathogen like this one requires a multi-pronged effort. Disinfection of high-touch and high-use areas, improving people's personal hygiene habits, social distancing, and lockdowns have helped keep the infection rate manageable in most areas in the case of this pandemic, though many have still died.

However, lockdowns can't go on forever, and many people are eager to get back to their usual routines. In order to open up responsibly, it's important to have adequate testing in place so that infections can be identified, and hopefully, we will be able to start tracing the contacts of people who are actively infected, and testing or isolating them. It will also be worthwhile to identify people who have had the infection but remained asymptomatic. And naturally, many people who have had serious illnesses over the past few months but could not be tested for many reasons are still curious about whether they may have had COVID-19.

While PCR-based or molecular tests can detect active infections relatively quickly, antibody tests can show who has been exposed to the virus. PCR tests look for pieces of the viral genome, while antibody tests detect immunoglobulins (antibodies) produced by the body's plasma cells in response to the virus.

There are now 92 approved molecular tests, 12 approved antibody tests, and approved one antigen test, according to Dr. Hahn.

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 02, 2020
Chemistry & Physics
How Can Far-Ultraviolet Light Help Us in a Pandemic?
JUN 02, 2020
How Can Far-Ultraviolet Light Help Us in a Pandemic?
Ultraviolet (UV) (10-400 nm) light is everywhere. It constitutes 10 percent of the total electromagnetic radiation in th ...
JUN 22, 2020
Microbiology
A Human Gut Microbe Can Help Maintain Healthy Cholesterol Levels
JUN 22, 2020
A Human Gut Microbe Can Help Maintain Healthy Cholesterol Levels
The world is full of microorganisms, and our bodies are one of the many places they have colonized. These gut microbes c ...
JUN 30, 2020
Plants & Animals
Consequences of Sixth Mass Extinction Threaten Humanity
JUN 30, 2020
Consequences of Sixth Mass Extinction Threaten Humanity
Many scientists have taken note of the rapid decline many of the world species, and several have declared that Earth's s ...
JUL 03, 2020
Cell & Molecular Biology
A Gut Pathogen Moves With Help From Its Environment
JUL 03, 2020
A Gut Pathogen Moves With Help From Its Environment
Campylobacter jejuni is a foodborne bacterial pathogen that causes millions of cases of food poisoning each year.
JUL 15, 2020
Microbiology
A Common Drug Could Help Reduce the Risk of COVID-19 Infections
JUL 15, 2020
A Common Drug Could Help Reduce the Risk of COVID-19 Infections
Heparin is a very common drug that's been approved as an anticoagulant since 1992. Researchers have now found that the m ...
JUL 27, 2020
Space & Astronomy
Bacteria More Lethal and Antibiotic Resistant in Space
JUL 27, 2020
Bacteria More Lethal and Antibiotic Resistant in Space
Research has shown that bacteria are more lethal and resistant to antibiotics when exposed to microgravity (a lack of gr ...
Loading Comments...